(Times of Israel) David Shamah - A cancer-detection technology that "sniffs out" malignant tumors is set to be commercialized, after a study showed that a device based on the Technion-developed "NaNose" system successfully detected lung cancer in patients with up to 90% accuracy. By detecting the special "odor" emitted by cancer cells, the NaNose system can detect the presence of both benign and malignant tumors much more quickly, efficiently and cheaply, said Dr. Hossam Haick of the Technion, who helped develop the technology. Lung cancer diagnoses require invasive procedures such as bronchoscopies, computer-guided biopsies or surgery. The NaNose-based breathalyzer, on the other hand, doesn't require anything more than a patient's breathing into the device in order to come up with an initial diagnosis.
2014-06-20 00:00:00Full ArticleBACK Visit the Daily Alert Archive